Quantcast
Last updated on April 16, 2014 at 5:23 EDT

Latest Sigma-Aldrich Co. LLC Stories

2014-01-17 08:22:49

ST. LOUIS, Jan. 17, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, will be launching the genetically-modified HepaRG human liver cell line, licensed from Biopredic, for hepatotoxicity and drug metabolism assays. Currently undergoing beta-testing by multiple contract research and pharmaceutical organizations, the assays will be publicly available later in Q1 2014 in a...

2013-07-30 08:32:55

ST. LOUIS, July 30, 2013 /PRNewswire/ -- Sigma-Aldrich (NASDAQ: SIAL), a leading Life Science and High Technology Company, announced today it has signed an agreement with Paragon Scientific to help develop Paragon's product range and to expand availability of Paragon's calibration standards and certified reference materials through Sigma-Aldrich sales and marketing channels. A new landing page, www.sigma-aldrich.com/paragon, has been established to provide customers with direct...

2013-02-13 08:27:32

ST. LOUIS, Feb. 13, 2013 /PRNewswire/ -- Sigma-Aldrich((R)) Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, through an exclusive collaboration with Drs. Hideo Iba and Takeshi Haraguchi at the University of Tokyo, released MISSION((R) )Synthetic and Lentiviral microRNA Inhibitors based upon the Tough Decoy (TuD) design for the long-term suppression of any miRNA endogenous to humans or mice. Custom designs for other...

2012-11-20 08:22:35

ST. LOUIS, Nov. 20, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced that Sigma Life Science, its innovative biological products and services business, today launched its CompoZr® Transporter Knockout human cell lines in a consumable, assay-ready plate format. The efflux transporter knockout cell lines allow precise identification of individual drug-transporter interactions, a critical component for understanding the safety and efficacy characteristics of drug...

2012-10-16 07:26:23

ST. LOUIS, Oct. 16, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma(®) Life Science, and Ekam Imaging, Inc. have partnered to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology. For more information on SAGE Labs,...

2012-10-15 07:28:25

ST. LOUIS, Oct. 15, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, initiated a licensing program aimed at contract research organizations (CROs) and pharmaceutical companies for its novel CompoZr(®) Transporter Knockout Cell Lines for preclinical ADME screening and safety studies. Complete functional knockouts of transporters in the intestinal cell line...

2012-08-02 02:30:18

ST. LOUIS, August 2, 2012 /PRNewswire/ -- Sigma-Aldrich(® )Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma(®) Life Science and Autism Speaks(®), the nation's largest autism science and advocacy organization, expanded a collaboration to develop the first rat models with modified autism associated genes, intended to accelerate discovery and translational autism research. Expansion of the collaboration follows...

2012-07-31 02:27:00

ST. LOUIS, July 31, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, has signed an agreement with Axiogenesis to market mouse induced pluripotent stem (iPS) cell-derived cardiomyocytes and smooth muscle cells. In contrast to short-lived, tissue-derived primary cells that predominate preclinical drug discovery and cardiotoxicity screens, Sigma Life Science and...

2012-07-25 02:29:00

ST. LOUIS, July 25, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (NASDAQ:SIAL) announced today its Supelco® brand launched the Ascentis® Express C18, 5 micron particle size column to improve speed and increase efficiencies in high purity liquid chomatography (HPLC) procedures. The new columns are based on innovative Fused-Core® particle technology, which enables the production of columns capable of achieving greater speed and efficiencies than conventional 5...

2012-04-19 02:28:55

ST. LOUIS, April 19, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma® Life Science, extended CompoZr® Zinc Finger Nuclease (ZFN) technology to achieve the first tissue-specific conditional knockout of an endogenous gene in rats. For two decades this approach for generating sophisticated disease models could be performed only in mice. Rats, however, are preferred by drug...